Several major pharmaceutical companies, including AstraZeneca and Boehringer Ingelheim, have implemented new out-of-pocket price caps for asthma inhalers, reducing the cost to $35 per month for many Americans. This initiative follows pressure from the Biden administration, Bernie Sanders, and public outcry over high inhaler prices.
After the HELP Committee I chair launched an investigation into inhalers that cost $645 in the US but just $49 in the UK, Boehringer Ingelheim & AstraZeneca agreed to cap the costs of the inhalers they make at $35 this month. Millions with asthma & COPD will benefit as a result. https://t.co/ADD8aKS1da
High demand and high prices keep drugs like Ozempic out of reach for diabetes patients on a fixed income, and why changing the kind of respiratory inhaler you use could be a better choice for the planet. Listen to the latest KFF Health News Minute: https://t.co/Evs0ygzZvF
GOOD NEWS! Inhaler prices for many Americans with asthma are now capped at $35/month! I was proud to lead the investigation into high inhaler prices & I'm glad to help lower Wisconsinitesβ health care costs! https://t.co/AZklAi4L1s
The cost of inhalers has now gone down to $35 for millions of Americans. The new caps have gone into effect for inhalers from AstraZeneca and Boehringer Ingelheim. This change comes after sustained pressure from the White House, Bernie Sanders, and the Democrats.
Because of the Biden-Harris administration's work, drug manufacturers are capping inhaler costs at $35 a month. For the 27M Americans with asthma like me, that's a huge sigh of relief. Making life-saving medication affordable is investing in America. https://t.co/u6rC6AMh4H
As of Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. https://t.co/YT6qlMtcl0
Following years of public outcry about the high cost, price caps for asthma inhalers from AstraZeneca and Boehringer Ingelheim have gone into effect. https://t.co/IPx8TvCjSK
Today, as a direct result of our investigation into the outrageously high cost of inhalers, the major pharmaceutical company Boehringer Ingelheim will now allow people with asthma and COPD to purchase brand name inhalers at their local drugstore for only $35. https://t.co/xyPTiJpk79
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for asthma medications. https://t.co/TSxITPh85U
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. https://t.co/FzonQOyQNR
Price caps for asthma inhalers from AstraZeneca and Boehringer Ingelheim will go into effect starting June 1. https://t.co/EqkVKO0dAi
Starting today, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. https://t.co/7zDR556Nc8
The cost of inhalers will be reduced for many Americans as new out-of-pocket price caps are expected to go in effect. @annenbcnews joins Saturday TODAY to discuss the new pricing for asthma medications. https://t.co/ON0o5Yvo4u
Some drugmakers to cap cost of asthma inhalers at $35 a month. https://t.co/27lnYIiaD8
THESE Companies Will Offer Inhalers At $35 After Pressure From #Biden https://t.co/AxLSgI4DsV